Cycuria Therapeutics Overview

  • Year Founded
  • 2024

Year Founded

  • Status
  • Private

  • Employees
  • 7

Employees

  • Latest Deal Type
  • Early Stage VC

  • Investors
  • 2

Cycuria Therapeutics General Information

Description

Developer of targeted protein-based therapies designed to treat blood cancers, particularly acute myeloid leukemia (AML). The company's platform focuses on engineered proteins that selectively target leukemic stem cells and AML blasts, enhancing the survival of healthy blood cells, reducing toxicity, and offering immune-stimulating properties, enabling more effective treatment for cancer patients while preserving healthy cell function, ultimately aiming to improve outcomes for patients with AML and potentially other hard-to-treat cancer types.

Contact Information

Website
www.cycuria.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Center for Knowledge Transfer II (ZWT II)
  • Medical Science City Graz, Stiftingtalstraße 14
  • Graz, 8010
  • Austria
Primary Industry
Drug Delivery
Other Industries
Biotechnology
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • Center for Knowledge Transfer II (ZWT II)
  • Medical Science City Graz, Stiftingtalstraße 14
  • Graz, 8010
  • Austria

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Cycuria Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Early Stage VC 01-Jan-2024 Completed Pre-Clinical Trials
1. Accelerator/Incubator Completed Pre-Clinical Trials
To view Cycuria Therapeutics’s complete valuation and funding history, request access »

Cycuria Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Cycuria Therapeutics Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
Wieland Capital Family Office Minority
ZWT Accelerator/Incubator
To view Cycuria Therapeutics’s complete investors history, request access »

Ready to get started?

Request a free trial

Cycuria Therapeutics FAQs

  • When was Cycuria Therapeutics founded?

    Cycuria Therapeutics was founded in 2024.

  • Where is Cycuria Therapeutics headquartered?

    Cycuria Therapeutics is headquartered in Graz, Austria.

  • What is the size of Cycuria Therapeutics?

    Cycuria Therapeutics has 7 total employees.

  • What industry is Cycuria Therapeutics in?

    Cycuria Therapeutics’s primary industry is Drug Delivery.

  • Is Cycuria Therapeutics a private or public company?

    Cycuria Therapeutics is a Private company.

  • What is Cycuria Therapeutics’s current revenue?

    The current revenue for Cycuria Therapeutics is .

  • Who are Cycuria Therapeutics’s investors?

    Wieland Capital and ZWT have invested in Cycuria Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process